S&P 500 7,718.60 −0.38%
Nasdaq 26,506.99 −0.29%
S&P/TSX 36,513.80 −0.33%
Apple 319.97 −2.51%
Nvidia 230.36 +0.84%
Microsoft 499.70 −2.04%
Shopify 200.76 −0.10%
Royal Bank 291.48 −0.30%
CAD/USD 0.7230 −0.30%
CLOSED · 17:40 ET
Market ClerkRecap
Sun Sep 6 · markets closed2 signals today321 insider buys this week · $404MCIRO short report next: Sep 15The week ahead

RLAY

Relay Therapeutics, Inc.
NASDAQ · HEALTH CARE · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
19.04
+0.03 +0.16%
USD · close Sep 4
MKT CAP $4.2BP/E DIV YIELD FCF YIELD REV TTM $10.3M +23.9%NET INCOME −$286MNET CASH 52W 3.99 – 20.75NEXT EARNINGS Nov 5 EST.SEC XBRL · TTM TO Invalid Date

What RLAY had to tell the SEC

FORM 8-K · TWO YEARS · MOST RECENT FIRST
No 8-K filings from RLAY on record yet. The events worker reads new filings each morning; older ones appear as the sweep reaches them.

Items read from each filing’s EDGAR index page; labels are ours. Every tracked company’s 8-Ks, most serious first.

Watch RLAY. Know when insiders buy.
One email the day a filing lands. Free.